MTM(SH:688029) Sou Hu Cai Jing·2025-08-04 11:53Group 1 - The core viewpoint of the articles highlights that Nanwei Medical's stock price has increased by 5.93% to 88.99 yuan, with a rolling PE ratio of 29.29, marking a new low in 377 days, and a total market capitalization of 16.717 billion yuan [1] - The average PE ratio for the medical device industry is 54.32, with a median of 38.11, placing Nanwei Medical at the 57th position in the industry ranking [1] - As of the first quarter of 2025, 17 institutions hold shares in Nanwei Medical, with a total of 5.4605 million shares valued at 369 million yuan [1] Group 2 - Nanwei Medical specializes in the research, manufacturing, and sales of minimally invasive medical devices, with key products including biopsy, hemostasis, closure devices, EMR/ESD devices, dilation devices, ERCP devices, EUS/EBUS devices, ablation instruments, and disposable imaging systems [1] - The latest financial results for the first quarter of 2025 show that the company achieved a revenue of 699 million yuan, a year-on-year increase of 12.75%, and a net profit of 161 million yuan, also reflecting a year-on-year increase of 12.18%, with a gross profit margin of 65.69% [1]